4-(tert-butyl)-N-phenethylbenzenesulfonamide

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(tert-butyl)-N-phenethylbenzenesulfonamide
• 英文别名: 4-tert-butyl-N-(2-phenylethyl)benzenesulfonamide
• 化学式: C₁₈H₂₃NO₂S
• 分子量: 317.452
• InChiKey: SSIGHDCPZUDZHA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  22
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  54.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-(tert-butyl)-N-phenethylbenzenesulfonamide 、 alkaline earth salt of/the/ methylsulfuric acid 在 sodium hydride 、 sodium iodide 、 羟胺 作用下， 以 N,N-二甲基甲酰胺 、 甲醇 为溶剂， 生成 3-[(4-tert-butylphenyl)sulfonyl-(2-phenylethyl)amino]-N-hydroxypropanamide
  参考文献：
  名称：

  Design and synthesis of procollagen C-proteinase inhibitors

  摘要：

  Non-peptidic inhibitors of procollagen C-proteinase (PCP) were designed from substrate leads. Compounds were optimized for potency and selectivity, with N-substituted aryl sulfonamide hydroxamates having the best combination of these properties. Compounds 89 and 60 have IC50 values of 10 and 80 nM, respectively, against PCP; excellent selectivity over MMP's 1, 2, and 9; and activity in cell-based collagen deposition assays. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.10.067
• 作为产物：
  描述：

  bis(4-tert-butylphenyl)disulfide 在 sodium hydrogen sulfate 、 sodium hypochlorite pentahydrate 、 magnesium oxide 作用下， 反应 2.0h， 生成 4-(tert-butyl)-N-phenethylbenzenesulfonamide
  参考文献：
  名称：

  通过可伸缩、环保且经济高效的工艺机械合成磺酰胺

  摘要：

  在此，我们展示了一种无溶剂机械化学方法，涉及由固体次氯酸钠（NaOCl·5H 2 O）介导的一锅双步程序，用于合成磺酰胺。该方案需要在催化固体酸性物质存在下对二硫化物进行串联氧化氯化反应，然后在路易斯酸碱固体无机试剂的促进下进行胺化。该方法适用于芳香族和脂肪族二硫化物和胺。纯化过程充分考虑了环境问题，避免了恶劣的条件，以获得纯净的磺酰胺产品。一些相关的生物活性化合物已经用此过程制备。

  DOI：

  10.1039/d3gc01894f

文献信息

• Phosphine/Photoredox Catalyzed Anti-Markovnikov Hydroamination of Olefins with Primary Sulfonamides via α-Scission from Phosphoranyl Radicals
  作者：Alex J. Chinn、Kassandra Sedillo、Abigail G. Doyle

  DOI：10.1021/jacs.1c09484

  日期：2021.11.3

  well-explored β-scission chemistry of phosphoranyl radicals, this strategy is applicable to activation of N-based nucleophiles and is catalytic in phosphine. We highlight application of this activation strategy to an intermolecular anti-Markovnikov hydroamination of unactivated olefins with primary sulfonamides. A range of structurally diverse secondary sulfonamides can be prepared in good to excellent yields

  从普通原料化学品中获取自由基的新策略具有广泛影响合成化学的潜力。我们报告了一种双膦和光氧化还原催化系统，该系统能够从伯磺酰胺中直接形成磺胺基自由基。机理研究支持 N 中心自由基是通过磷酰基自由基中间体的 P-N 键的 α 断裂产生的，该中间体由磺酰胺亲核加成到膦自由基阳离子形成。与最近充分探索的磷酰基自由基的 β- 断裂化学相比，该策略适用于 N 基亲核试剂的活化，并且在膦中具有催化作用。我们重点介绍了这种活化策略在未活化烯烃与伯磺酰胺的分子间抗马尔科夫尼科夫加氢胺化中的应用。
• 6-Aminoisoquinoline Compounds
  申请人：deLong Mitchell A.

  公开号：US20080167340A1

  公开（公告）日：2008-07-10

  6-Amino isoquinoline compounds are provided that influence, inhibit or reduce the action of a kinase. Pharmaceutical compositions including therapeutically effective amounts of the 6-aminoisoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, obesity and glaucoma are also provided.

  提供了影响、抑制或减少激酶作用的6-氨基异喹啉化合物。还提供了包括治疗有效量的6-氨基异喹啉化合物和药用可接受载体的药物组合物。还提供了使用这些化合物和/或组合物来影响疾病状态或疾病条件，如癌症、肥胖和青光眼的各种方法。
• 6-AMINOISOQUINOLINE COMPOUNDS
  申请人：deLong Mitchell A.

  公开号：US20110183965A1

  公开（公告）日：2011-07-28

  6-Amino isoquinoline compounds are provided that influence, inhibit or reduce the action of a kinase. Pharmaceutical compositions including therapeutically effective amounts of the 6-aminoisoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, obesity and glaucoma are also provided.

  本发明提供了影响、抑制或减少激酶作用的6-氨基异喹啉化合物。还提供了包括治疗有效量的6-氨基异喹啉化合物和药学上可接受的载体的制药组合物。还提供了使用这些化合物和/或组合物影响疾病状态或病症，如癌症、肥胖和青光眼的各种方法。
• 6-aminoisoquinoline compounds
  申请人：Aerie Pharmaceuticals, Inc.

  公开号：US10472327B2

  公开（公告）日：2019-11-12

  6-Amino isoquinoline compounds are provided that influence, inhibit or reduce the action of a kinase. Pharmaceutical compositions including therapeutically effective amounts of the 6-aminoisoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, obesity and glaucoma are also provided.

  提供了可影响、抑制或减少激酶作用的 6-氨基异喹啉化合物。还提供了包括治疗有效量的 6-氨基异喹啉化合物和药学上可接受的载体的药物组合物。还提供了使用这些化合物和/或组合物影响癌症、肥胖症和青光眼等疾病状态或病症的各种方法。
• Expedient synthesis of secondary amines bound to indole resin and cleavage of resin-bound urea, amide and sulfonamide under mild conditions
  作者：Sukanta Bhattacharyya、Owen W. Gooding、Jeff Labadie

  DOI：10.1016/s0040-4039(03)01456-4

  日期：2003.8

  Highly efficient, new protocols for the attachment of primary amines to indole aldehyde resin using Ti((OPr)-Pr-i)(4)-NaBH4 and CH(OMe)(3)-NaBH3CN-HOAc are reported. Mild cleavage conditions for the release of urea, amide and sulfonamide products from the solid support using 1% trifluoroacetic acid (TFA) are developed. (C) 2003 Elsevier Ltd. All rights reserved.